chloramphenicol has been researched along with Prostatic Hyperplasia in 3 studies
Amphenicol: Chloramphenicol and its derivatives.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, SL | 1 |
| Malhotra, VK | 1 |
| Marshall, A | 1 |
| Mishina, T | 1 |
| Fujimura, S | 1 |
| Murata, S | 1 |
| Oyama, C | 1 |
| Murakami, T | 1 |
3 other studies available for chloramphenicol and Prostatic Hyperplasia
| Article | Year |
|---|---|
Urinary tract infections in surgical cases.
Topics: Chloramphenicol; Escherichia coli Infections; Female; Humans; Male; Nitrofurantoin; Prostatic Hyperp | 1972 |
Retropubic prostatectomy: a review with special reference to urinary infection.
Topics: Aged; Chloramphenicol; Chlortetracycline; Hemorrhage; Humans; Male; Middle Aged; Oxytetracycline; Pe | 1967 |
[Clinical experiences with intravenous use of "Chlotaon" in urological diseases].
Topics: Adult; Aged; Child; Chloramphenicol; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pro | 1968 |